IL2 and collecting duct carcinoma: Oudard et al found a 26% remission rate in BDC following use of Gemcitabine + Cisplatin/Carboplatin combination while Tokuda et al in Japan found interferon (IFN) and interleukin-2 (IL-2) to be ineffective [6, 15].